BridgeBio Pharma
BBIO
BBIO
302 hedge funds and large institutions have $6.41B invested in BridgeBio Pharma in 2025 Q1 according to their latest regulatory filings, with 74 funds opening new positions, 119 increasing their positions, 78 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
302
Holders Change
+40
Holders Change %
+15.27%
% of All Funds
4.1%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.24%
New
74
Increased
119
Reduced
78
Closed
30
Calls
$472M
Puts
$80.1M
Net Calls
+$392M
Net Calls Change
+$79.7M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GCM
326
Graham Capital Management
Rowayton,
Connecticut
| – | -$130K | -4,725 | Closed |
|
327
PEAK6
Chicago,
Illinois
| – | -$98.8K | -3,600 | Closed |
|
|
EC
328
Elequin Capital
New York
| – | -$8.31K | -303 | Closed |
|
|
ETC
329
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| – | -$6.09K | -222 | Closed |
|
|
SIS
330
Sound Income Strategies
Ft Lauderdale,
Florida
| – | -$2.74K | -100 | Closed |
|
|
CTA
331
Colonial Trust Advisors
Spartanburg,
South Carolina
| – | -$604 | -22 | Closed |
|
|
PPWM
332
PFG Private Wealth Management
Lutz,
Florida
| – | -$302 | -11 | Closed |
|